当前位置: X-MOL 学术BMC Struct. Biol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Three-dimensional models of Mycobacterium tuberculosis proteins Rv1555, Rv1554 and their docking analyses with sildenafil, tadalafil, vardenafil drugs, suggest interference with quinol binding likely to affect protein's function.
BMC Structural Biology Pub Date : 2018-04-18 , DOI: 10.1186/s12900-018-0085-4
Pallabini Dash 1 , M Bala Divya 2 , Lalitha Guruprasad 2 , Kunchur Guruprasad 1
Affiliation  

BACKGROUND Earlier based on bioinformatics analyses, we had predicted the Mycobacterium tuberculosis (M.tb) proteins; Rv1555 and Rv1554, among the potential new tuberculosis drug targets. According to the 'TB-drugome' the Rv1555 protein is 'druggable' with sildenafil (Viagra), tadalafil (Cialis) and vardenafil (Levitra) drugs. In the present work, we intended to understand via computer modeling studies, how the above drugs are likely to inhibit the M.tb protein's function. RESULTS The three-dimensional computer models for M.tb proteins; Rv1555 and Rv1554 constructed on the template of equivalent membrane anchor subunits of the homologous E.coli quinol fumarate reductase respiratory protein complex, followed by drug docking analyses, suggested that the binding of above drugs interferes with quinol binding sites. Also, we experimentally observed the in-vitro growth inhibition of E.coli bacteria containing the homologous M.tb protein sequences with sildenafil and tadalafil drugs. CONCLUSIONS The predicted binding sites of the drugs is likely to affect the above M.tb proteins function as quinol binding is known to be essential for electron transfer function during anaerobic respiration in the homologous E.coli protein complex. Therefore, sildenafil and related drugs currently used in the treatment of male erectile dysfunction targeting the human phosphodiesterase 5 enzyme may be evaluated for their plausible role as repurposed drugs to treat human tuberculosis.

中文翻译:

结核分枝杆菌蛋白Rv1555,Rv1554的三维模型及其与西地那非,他达拉非,伐地那非药物的对接分析表明,干扰喹诺酮的结合可能会影响蛋白质的功能。

背景技术早先基于生物信息学分析,我们已经预测了结核分枝杆菌(M.tb)蛋白。Rv1555和Rv1554是潜在的新型结核药物靶标。根据“ TB-药物组”的说法,Rv1555蛋白可与西地那非(Viagra),他达拉非(Cialis)和伐地那非(Levitra)药物“吸毒”。在当前的工作中,我们打算通过计算机建模研究来了解上述药物如何可能抑制M.tb蛋白的功能。结果M.tb蛋白质的三维计算机模型;Rv1555和Rv1554构建在同源大肠杆菌富马酸喹诺酮还原酶呼吸蛋白复合物的等效膜锚亚基模板上,然后进行药物对接分析,表明上述药物的结合会干扰喹诺酮的结合位点。也,我们通过实验观察了含有西地那非和他达拉非药物的含有同源M.tb蛋白序列的大肠杆菌的体外生长抑制作用。结论药物的预测结合位点可能会影响上述M.tb蛋白的功能,因为已知在已知的大肠杆菌蛋白复合物中厌氧呼吸过程中,喹诺醇结合对于电子转移功能至关重要。因此,可以评估目前用于靶向人磷酸二酯酶5酶的男性勃起功能障碍的西地那非和相关药物作为治疗人类结核病的改用药物的合理作用。结论药物的预测结合位点可能会影响上述M.tb蛋白的功能,因为已知在已知的大肠杆菌蛋白复合物中厌氧呼吸过程中,喹诺醇结合对于电子转移功能至关重要。因此,可以评估目前用于靶向人磷酸二酯酶5酶的男性勃起功能障碍的西地那非和相关药物作为治疗人类结核病的改用药物的合理作用。结论药物的预测结合位点可能会影响上述M.tb蛋白的功能,因为已知在已知的大肠杆菌蛋白复合物中厌氧呼吸过程中,喹诺醇结合对于电子转移功能至关重要。因此,可以评估目前用于靶向人磷酸二酯酶5酶的男性勃起功能障碍的西地那非和相关药物作为治疗人类结核病的改用药物的合理作用。
更新日期:2018-04-18
down
wechat
bug